Research programme: neurodegenerative diseases diagnostics and therapeutics - AC Immune

Drug Profile

Research programme: neurodegenerative diseases diagnostics and therapeutics - AC Immune

Alternative Names: a-syn-PET imaging agent - AC Immune; Alpha-synuclein inhibitors - AC Immune; Alpha-synuclein-PET based diagnostics and therapeutics - AC Immune; Anti-TDP-43 antibody; Morphomer Tau; Morphomer α-syn inhibitors - AC Immune; Tau Morphomer; Tau-PET imaging agent - AC Immune

Latest Information Update: 28 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator AC Immune
  • Developer AC Immune; Biogen
  • Class Antibodies; Antidementias; Imaging agents; Radiopharmaceutical diagnostics; Small molecules
  • Mechanism of Action Alpha-synuclein inhibitors; Positron-emission tomography enhancers; Tau protein inhibitors; TDP-43 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Alzheimer's disease
  • Research Dementia; Parkinson's disease; Unspecified

Most Recent Events

  • 05 Apr 2018 AC Immune plans a phase I trial for Tau Morphomer for Alzheimer's disease by end of 2018
  • 20 Mar 2018 Early research in Undefined indication in Switzerland (unspecified route)
  • 15 Mar 2018 AC Immune plan to initiate clinical studies for the PET tracer programme in the second half of 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top